BioSpace News Archive

The U.S. Food and Drug Administration (FDA) approved Italy-based Cassiopea SpA’s acne treatment Winlevi. Let’s look at how this new acne treatment was developed.

With a new regulatory approval in hand for its FoundationOne Liquid CDx, Foundation Medicine said it plans for the product to be available for commercial use by Friday, Aug. 28.

The trials were identical, multi-center, randomized, vehicle-controlled, double-blind, parallel studies that evaluated tapinarof cream, 1% in adults with plaque psoriasis.

The idea is to support companies that anticipate “potential health security threats, activating the global innovation community, and amplifying scientific and technological advances with the aim to prepare for and respond to our rapidly evolving global health environment.”

New investors who joined the funding round include Viking Global Investors, Venrock Healthcare Capital Partners and Janus Henderson Investors.

When someone gets sick with COVID-19, there is a lag in an efficient immune response, giving the virus time to do significant damage before the immune system can reign in the infection.

Keep these tips for virtual meetings in mind the next time you’re getting ready to log on to a video conference and want to keep your attention span in check.

Dr. Reddy’s Laboratories Ltd. announced the launch of Penicillamine Capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine® Capsules, 250 mg, approved by the U.S. Food and Drug Administration.

ViaDerma, Inc., is pleased to provide this update on its current marketing efforts and ongoing product trials of its topical antibiotic, Vitastem.

Electromedical Technologies, Inc., a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro®, designed to relieve chronic, intractable and acute pain by using frequencies and electro-modulation, issues the following Letter to Shareholders on behalf of the CEO: